PMID- 10373119 OWN - NLM STAT- MEDLINE DCOM- 19990707 LR - 20220309 IS - 0036-8075 (Print) IS - 0036-8075 (Linking) VI - 284 IP - 5422 DP - 1999 Jun 18 TI - Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. PG - 1994-8 AB - In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth. FAU - Holash, J AU - Holash J AD - Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA. FAU - Maisonpierre, P C AU - Maisonpierre PC FAU - Compton, D AU - Compton D FAU - Boland, P AU - Boland P FAU - Alexander, C R AU - Alexander CR FAU - Zagzag, D AU - Zagzag D FAU - Yancopoulos, G D AU - Yancopoulos GD FAU - Wiegand, S J AU - Wiegand SJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Science JT - Science (New York, N.Y.) JID - 0404511 RN - 0 (Angiopoietin-1) RN - 0 (Angiopoietin-2) RN - 0 (Angpt1 protein, mouse) RN - 0 (Angpt1 protein, rat) RN - 0 (Endothelial Growth Factors) RN - 0 (Lymphokines) RN - 0 (Membrane Glycoproteins) RN - 0 (Proteins) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (Vascular Endothelial Growth Factors) SB - IM MH - Adenocarcinoma/blood supply/pathology MH - Angiopoietin-1 MH - Angiopoietin-2 MH - Animals MH - Apoptosis MH - Blood Vessels/pathology MH - Endothelial Growth Factors/genetics/*physiology MH - Endothelium, Vascular/pathology/physiology MH - Glioblastoma/blood supply/pathology MH - Glioma/blood supply/pathology MH - In Situ Hybridization MH - Lymphokines/genetics/*physiology MH - Male MH - Membrane Glycoproteins/genetics/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Muscle, Smooth, Vascular/pathology/physiology MH - Neoplasm Transplantation MH - Neoplasms, Experimental/*blood supply/*pathology MH - *Neovascularization, Pathologic MH - Proteins/genetics/*physiology MH - Rats MH - Rats, Sprague-Dawley MH - Up-Regulation MH - Vascular Endothelial Growth Factor A MH - Vascular Endothelial Growth Factors EDAT- 1999/06/18 00:00 MHDA- 1999/06/18 00:01 CRDT- 1999/06/18 00:00 PHST- 1999/06/18 00:00 [pubmed] PHST- 1999/06/18 00:01 [medline] PHST- 1999/06/18 00:00 [entrez] AID - 7601 [pii] AID - 10.1126/science.284.5422.1994 [doi] PST - ppublish SO - Science. 1999 Jun 18;284(5422):1994-8. doi: 10.1126/science.284.5422.1994.